Bank of New York Mellon Corp - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 125 filers reported holding IMMUNOVANT INC in Q1 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$7,379,096
+113.1%
192,214
+5.3%
0.00%
+100.0%
Q2 2023$3,463,278
+32.1%
182,566
+8.0%
0.00%0.0%
Q1 2023$2,622,338
-11.8%
169,074
+0.9%
0.00%0.0%
Q4 2022$2,973,303
+256.1%
167,510
+11.9%
0.00%
Q3 2022$835,000
+51.3%
149,674
+5.8%
0.00%
Q2 2022$552,000
-31.8%
141,433
-3.7%
0.00%
Q1 2022$809,000
-34.9%
146,799
+0.6%
0.00%
Q4 2021$1,243,000
+1.8%
145,866
+3.8%
0.00%
Q3 2021$1,221,000
-6.0%
140,473
+14.3%
0.00%
Q2 2021$1,299,000
-45.6%
122,868
-17.5%
0.00%
Q1 2021$2,389,000
-69.0%
148,950
-10.9%
0.00%
-100.0%
Q4 2020$7,718,000
+42.0%
167,111
+8.2%
0.00%
+100.0%
Q3 2020$5,434,000
+197.1%
154,446
+105.6%
0.00%
Q2 2020$1,829,00075,1040.00%
Other shareholders
IMMUNOVANT INC shareholders Q1 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,000,200$26,072,0005.92%
MANGROVE PARTNERS IM, LLC 1,139,900$9,906,0000.89%
Eventide Asset Management 4,950,000$43,016,0000.57%
Ghost Tree Capital, LLC 200,000$1,738,0000.51%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,221,0000.47%
FRAZIER MANAGEMENT LLC 585,759$5,090,0000.41%
MANGROVE PARTNERS IM, LLC 500,000$4,345,0000.39%
EcoR1 Capital, LLC 1,140,819$9,914,0000.34%
BCK CAPITAL MANAGEMENT LP 53,459$465,0000.28%
PLATINUM INVESTMENT MANAGEMENT LTD 555,065$4,824,0000.14%
View complete list of IMMUNOVANT INC shareholders